Exhaled breath condensate

R. Dekhuijzen (Nijmegen, The Netherlands)

Source: Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease
Session: PG18 - Markers of inflammation in obstructive airway disease
Session type: Postgraduate Course
Number: 101
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Dekhuijzen (Nijmegen, The Netherlands). Exhaled breath condensate. Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled breath condensates
Source: Eur Respir Mon; 2010: 47: 155–182
Year: 2010

Exhaled breath condensates and COPD
Source: Eur Respir J 2009; 33: 1238
Year: 2009


Exhaled breath condensate pH
Source: Eur Respir J 2004; 23: 961-962
Year: 2004


Exhaled breath condensate contains more than only volatiles
Source: Eur Respir J 2003; 22: 187-188
Year: 2003


Methodology of exhaled breath condensate
Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide
Year: 2009


Exhaled breath condensate: metabolomics
Source: Eur Respir Monogr 2010; 49: 231-236
Year: 2010


Parameters of oxidation in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 470s
Year: 2004

Exhaled nitric oxide and exhaled breath condensate pH in smoking asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009


Reproducibility of exhaled breath condensate markers
Source: Eur Respir J 2008; 32:
Year: 2008


Fractionated sampling of exhaled breath condensate
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Year: 2007


Correlation of LTB4 with α-amylase in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005

Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002

Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification
Source: Eur Respir J 2007; 30: Suppl. 51, 364s
Year: 2007

Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007



Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008


Exhaled breath temperature in asthma
Source: Eur Respir J 2003; 21: 195
Year: 2003